NASDAQ:HOWL
Werewolf Therapeutics, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
werewolftx.comipo date
Apr 30, 2021
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies....Show More
Earnings
Earnings Release in 13 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus